Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03704714
Title Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Northwestern University
Indications

B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Nivolumab + Prednisone + Rituximab + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Recruiting Chicago Illinois 60611 United States Details
Rush University Medical Center Recruiting Chicago Illinois 60612 United States Details
Northwestern University- Lake Forest Hospital Recruiting Lake Forest Illinois 60045 United States Details
Northwestern Medicine: Delnor, DuPage, Warrenville, Kishwaukee (West Region) Recruiting Warrenville Illinois 60555 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field